CCP110 and ovarian cancer: Ovarian cancer patients with higher levels of KATNA1 exhibit better overall survival (90); higher CP110 can decrease breast cancer cell invasion (91), yet lung cancer tissue expresses higher CP110 than the normal lung (92), while TERT is largely oncogenic (93).